--FILE--View of the office building of Shenzhen Hepalink Pharmaceutical Co. in Shenzhen city, south Chinas Guangdong province, 26 April 2010. Shenzh
Image details
Contributor:
Imaginechina Limited / Alamy Stock PhotoImage ID:
W94CJXFile size:
23.3 MB (1.2 MB Compressed download)Releases:
Model - no | Property - noDo I need a release?Dimensions:
2325 x 3500 px | 19.7 x 29.6 cm | 7.8 x 11.7 inches | 300dpiDate taken:
26 April 2010Photographer:
ImaginechinaMore information:
--FILE--View of the office building of Shenzhen Hepalink Pharmaceutical Co. in Shenzhen city, south Chinas Guangdong province, 26 April 2010. Shenzhen Hepalink Pharmaceutical Co. agreed to acquire Scientific Protein Laboratories LLC. for $337.5 million to strengthen the quality of Shenzhens blood clot prevention drug. Shenzhen, the Chinese maker of blood-thinner Heparin, is buying Scientific Protein, a supplier of pharmaceutical ingredients with 204 employees based in Wisconsin. Both companies say the deal will expand their markets and allow better access to raw materials to manufacture Heparin. Prior to its initial public offering more than three years ago, Shenzhen battled claims that its product, made from pig intestines, is tainted.